Meningitis B Vaccine Rollout: New JCVI Recommendations After Kent Outbreak

On 16 July 2026, the Joint Committee on Vaccination and Immunisation (JCVI) published a recommendation that could reshape how the UK protects its teenagers from meningitis B. The advice, now with the Department of Health and Social Care for consideration, calls for a routine adolescent MenB vaccination programme. For Helen and Lee Draper, parents of an 18-year-old who died from the disease, the news is a "poignant moment" that they believe will save countless lives.

A preventable tragedy

Meg Draper, a physiotherapy student from Pontypool, Torfaen, died from meningitis B in October 2025, just five weeks into her first term at the University of Bournemouth. She had quickly settled into university life, joining the swimming and netball teams. Her mother described her as "sporty, gregarious, outgoing, really charismatic, and chatty." Meg had been vaccinated against meningitis strains A, C, W, and Y at age 14 through the NHS schedule, but she did not receive the MenB vaccine. The bacteria that causes meningitis spreads like the common cold, and university students face higher risk because of social mixing with many new people.

Her parents now urge governments to act swiftly on the new guidance. "Make sure no more families have to endure the anguish, sorrow and devastation we have faced," they said.

What the JCVI recommends

The JCVI's recommendation, published on 16 July 2026, follows an unprecedented outbreak of MenB disease in Kent earlier this year. That outbreak prompted the Secretary of State for Health and Social Care to request a review of routine adolescent MenB vaccination. The committee considered new evidence on the effectiveness of a single additional dose of the 4CMenB vaccine in adolescents who had already received the vaccine in infancy.

The JCVI recommends a routine offer of one dose of the 4CMenB vaccine at around age 15 for adolescents who were eligible for MenB vaccination in infancy — those born on or after 1 May 2015. The first cohort this applies to will turn 15 in 2030. For adolescents born on or before 30 April 2015, who are considered "unprimed," the JCVI strongly supports an offer of two doses. It also backs a catch-up programme for adolescents who would be too young for the one-off offer announced on 12 June 2026, or too old for the 15-year-old programme.

From cost-effectiveness to public health priority

The shift in official advice is notable. Previously, the JCVI had said a routine adolescent MenB programme was not cost-effective. The new recommendation, driven by the Kent outbreak and fresh evidence, signals a change in the public health calculus. The Department of Health and Social Care will now consider the recommendation before any decision is made on changes to the NHS MenB vaccination schedule.

The Welsh government noted that implementation takes time and must consider affordability, feasibility, and the effect on the wider NHS. Similar considerations will apply across the UK as governments weigh the logistics of a new vaccination programme.

What this means for families

For parents of teenagers, the recommendation offers a clearer path to protection. Meningitis B is a rare but devastating disease that can kill within hours. The bacteria that cause it are carried in the nose and throat and spread through close contact — the kind of contact that defines university life. The JCVI's recommendation, if adopted, would close a gap in the current vaccination schedule that left many adolescents vulnerable.

Meg Draper's story is a stark reminder of what is at stake. Her parents have turned their grief into advocacy, and the JCVI's recommendation is a direct response to the kind of tragedy their family endured. As Helen Draper put it, the new advice represents a "poignant moment" that will save lives.

Next steps

The timeline for implementation is not yet set. The DHSC will review the JCVI's recommendation, and any change to the NHS schedule will require government approval. For the first cohort of primed adolescents, the programme would not begin until 2030, when those born on or after 1 May 2015 turn 15. But the catch-up programme for unprimed adolescents could begin sooner, depending on government decisions.

In the meantime, the message from public health officials and bereaved parents is the same: awareness saves lives. Meningitis B can strike anyone, but adolescents and young adults are at particular risk. The JCVI's recommendation is a step toward making sure no more families have to endure what the Drapers have been through.